Total Payments
$3,756
2024 Payments
$644.11
Companies
26
Transactions
182
Medicare Patients
1,557
Medicare Billing
$136,994
Payment Breakdown by Category
Food & Beverage$3,741 (99.6%)
Education$15.27 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,741 | 181 | 99.6% |
| Education | $15.27 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $779.23 | 45 | $0 (2024) |
| Allergan, Inc. | $694.26 | 39 | $0 (2021) |
| ABBVIE INC. | $501.34 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $419.51 | 25 | $0 (2022) |
| REVANCE THERAPEUTICS, INC. | $361.79 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $189.32 | 9 | $0 (2022) |
| PFIZER INC. | $104.89 | 3 | $0 (2023) |
| GENZYME CORPORATION | $91.70 | 4 | $0 (2018) |
| PruGen, Inc. Pharmaceuticals | $74.00 | 2 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $68.26 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $644.11 | 23 | REVANCE THERAPEUTICS, INC. ($361.79) |
| 2023 | $307.39 | 9 | AbbVie Inc. ($109.97) |
| 2022 | $256.96 | 11 | ABBVIE INC. ($83.06) |
| 2021 | $405.53 | 19 | AbbVie Inc. ($96.57) |
| 2020 | $148.36 | 8 | Novartis Pharmaceuticals Corporation ($36.22) |
| 2019 | $308.15 | 24 | Allergan Inc. ($110.05) |
| 2018 | $713.40 | 35 | Allergan Inc. ($253.80) |
| 2017 | $972.27 | 53 | Allergan Inc. ($243.78) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $32.99 | General |
| 10/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.76 | General |
| 10/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $27.74 | General |
| 09/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/11/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $24.08 | General |
| 08/27/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $41.28 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/23/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $35.19 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $45.19 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.39 | General |
| 07/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $9.73 | General |
| 06/28/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $87.43 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/06/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $41.45 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.22 | General |
| 05/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/26/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $50.31 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/09/2024 | REVANCE THERAPEUTICS, INC. | — | Food and Beverage | In-kind items and services | $7.82 | General |
| 03/26/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 03/15/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $24.86 | General |
| 03/05/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| 02/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.52 | General |
| 01/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $8.15 | General |
| 11/13/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 354 | 759 | $71,296 | $27,752 |
| 2022 | 7 | 386 | 909 | $55,628 | $34,527 |
| 2021 | 8 | 385 | 879 | $54,225 | $35,441 |
| 2020 | 10 | 432 | 1,001 | $64,339 | $39,274 |
Total Patients
1,557
Total Services
3,548
Medicare Billing
$136,994
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 121 | $18,763 | $7,292 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 75 | $15,523 | $6,245 | 40.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 60 | 73 | $14,706 | $6,135 | 41.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 74 | 107 | $12,520 | $4,148 | 33.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 26 | 29 | $5,502 | $2,039 | 37.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 54 | 354 | $4,283 | $1,893 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 140 | $14,778 | $9,582 | 64.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 68 | $9,860 | $6,915 | 70.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 55 | 70 | $9,505 | $6,338 | 66.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 72 | 108 | $8,496 | $4,315 | 50.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 44 | 54 | $8,404 | $3,961 | 47.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 59 | 455 | $3,640 | $2,759 | 75.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 11 | 14 | $944.16 | $656.60 | 69.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 138 | $14,444 | $9,470 | 65.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 68 | $9,780 | $7,025 | 71.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 53 | 68 | $9,214 | $6,099 | 66.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 65 | 98 | $7,710 | $4,535 | 58.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 55 | 441 | $3,528 | $2,639 | 74.8% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 13 | 17 | $3,230 | $2,584 | 80.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 29 | 35 | $5,419 | $2,484 | 45.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 14 | $900.00 | $604.80 | 67.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 133 | $16,625 | $10,504 | 63.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 55 | 70 | $9,160 | $6,867 | 75.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 73 | 119 | $9,073 | $4,887 | 53.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 52 | 64 | $9,600 | $4,563 | 47.5% |
About Dr. Nancy Samolitis, M.D
Dr. Nancy Samolitis, M.D is a Dermatology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1164688230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Samolitis, M.D has received a total of $3,756 in payments from pharmaceutical and medical device companies, with $644.11 received in 2024. These payments were reported across 182 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,741).
As a Medicare-enrolled provider, Samolitis has provided services to 1,557 Medicare beneficiaries, totaling 3,548 services with total Medicare billing of $136,994. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Long Beach, CA
- Active Since 07/29/2008
- Last Updated 04/18/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1164688230
Products in Payments
- COSENTYX (Biological) $394.99
- DAXXIFY (Drug) $353.97
- SKYRIZI (Biological) $270.13
- BOTOX COSMETIC (Biological) $175.77
- Humira (Biological) $168.38
- DERMATITIS - DISEASE (Drug) $91.70
- TREMFYA (Drug) $83.44
- REMICADE (Biological) $78.14
- BOTOX (Biological) $65.64
- ENSTILAR (Drug) $65.64
- KYBELLA (Biological) $58.19
- SOOLANTRA (Drug) $53.74
- SPEVIGO (Drug) $52.17
- RHOFADE (Drug) $47.16
- BLU-U (Medical Supply) $41.09
- TALTZ (Drug) $38.91
- Otezla (Drug) $33.16
- OPZELURA (Drug) $28.96
- GUSELKUMAB (Biological) $27.74
- Acticlate (Drug) $26.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Long Beach
K. Andrew Cerveny, Md, MD
Dermatology — Payments: $137,371
Dermatology $137,371
Dr. Charisse Dolitsky, Md, MD
Dermatology — Payments: $13,879
Dermatology $13,879
Mrs. Hong Nguyen, M.d, M.D
Dermatology — Payments: $10,495
Dermatology $10,495
Mr. Alan Heller, Md, MD
Dermatology — Payments: $9,633
Dermatology $9,633
Dr. Katie Osley, M.d, M.D
Dermatology — Payments: $9,391
Dermatology $9,391
Misha Heller, M.d, M.D
Dermatology — Payments: $8,828
Dermatology $8,828